Summary
This prediction ended on 15.06.15 with a price of €3.43. The price of Evotec SE has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.72%. wiltrud has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | 7.842% | 7.842% | -40.761% | -71.210% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
Comments by wiltrud for this prediction
In the thread Evotec AG diskutieren
Große Visionen
Die Evotec AG zählt zu den weltweit führenden Wirkstoffforschungs- und -entwicklungsunternehmen. Evotec AG ist auf Neurowissenschaften, Schmerz, Stoffwechsel- und Entzündungskrankheiten sowie Onkologie spezialisiert. Das Kerngeschäft bildet die Wirkstoffforschung, die in Kooperation mit Partnerunternehmen aus der Pharma- und Biotechnologieindustrie realisiert wird.
Die Vision geht hin zu einer Kooperation mit Google und Co.
"Wir sind der perfekte Brückenschlag für Unternehmen wie Google, um sich in diesem Bereich gut aufzustellen", sagt Evotec-Chef Werner Lanthaler in einem Interview mit der Nachrichtenagentur Reuters.
http://www.boerse-online.de/nachrichten/aktien/Evotec-Aktie-Biotechfirma-bringt-sich-als-Partner-von-Google-ins-Spiel-1000597331